IGM Biosciences, Inc. is a pioneering biotechnology company based in Mountain View, CA, dedicated to reimagining antibody medicines for the treatment of cancer, autoimmune, and inflammatory diseases. Leveraging the unique binding power of IgM antibodies, IGM has developed a cutting-edge research and development program focused on engineered therapeutic IgM antibodies, aiming to create novel therapeutic options and bring hope to patients.
By pushing the boundaries of scientific exploration, IGM Biosciences has introduced a new class of antibodies that offer innovative approaches to disease treatment. With a focus on expanding and enhancing the inherent qualities of IgM antibodies, the company is committed to developing a range of therapeutic antibodies for cancer and autoimmune and inflammatory diseases, making a significant impact in the field of biomedicine.
Generated from the website